معرفی
Mark Molloy is a Professor and Deputy Vice-Chancellor (Research) at Macquarie University, with an honorary role at the University of Sydney's Department of Molecular Sciences. His expertise lies in proteomics, particularly applying mass spectrometry to cancer research and translational medicine. He leads projects focused on biomarker discovery for cancers like colon, thyroid, and pancreatic, as well as pharmacokinetic monitoring using proteomic techniques.
Educational Background
- PhD in Proteomic Sciences from Macquarie University (supervised by Keith Williams)
- Postdoctoral research at the University of Michigan Medical School
- Industry experience at Pfizer Inc., followed by an NHMRC Career Development Fellowship studying colorectal cancer
Research Interests
Molloy's work emphasizes translational applications of proteomics, including:
- Quantitative targeted proteomics for cancer biomarker identification
- Pharmacokinetic analysis using dried blood spots
- Collaborative projects in oncology and neurodegenerative diseases
Awards & Grants
With over $42.9M in grant funding and 14 HDR student completions, Molloy's achievements include:
- Director of the Australian Proteome Analysis Facility (2010–2018)
- Scopus citations exceeding 5,000
Labs & Teams
He oversees infrastructure supporting ~100 academic/industry collaborators annually through the Australian Proteome Analysis Facility, fostering proteomic research across disciplines.
